Kimberly-Clark to buy Tylenol owner Kenvue in $48.7 bn deal

US consumer goods giant Kimberly-Clark announced Monday a $48.7 billion deal to acquire the major health company Kenvue, whose Tylenol painkiller has faced Trump administration allegations of links to increased autism risks.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup